Evidence map›Paper›PMID 36896648›Full record

ArticleEpilepsia open2023

Knowledge and misconceptions about epilepsy among people with epilepsy and their caregivers attending mental health clinics: A qualitative study in Taenia solium endemic pig-keeping communities in Tanzania.

Charles E Makasi, Andrew M Kilale, Bernard J Ngowi, Yakobo Lema, Victor Katiti, Michael J Mahande, Elizabeth F Msoka, Dominik Stelzle, Andrea S Winkler, Blandina T Mmbaga

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Epilepsia open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06376396 (Assessment of Combined Antiparasitic Drugs Praziquantel and Albendazole Versus Albendazole Alone in the Treatment of Active Parenchymal Neurocysticercosis in Tanzania and Zambia), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06376396 phase4not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Assessment of Combined Antiparasitic Drugs Praziquantel and Albendazole Versus Albendazole Alone in the Treatment of Active Parenchymal Neurocysticercosis in Tanzania and Zambia

TypeinterventionalSponsorR-Evolution Worldwide S.r.l. Impresa SocialeRan2024 to 2026Enrolled300ConditionsNeurocysticercosisArmsalbendazole and praziquantel, Albendazole
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Antiepileptic and antiepileptogenic effects ofIBRO neuroscience reports · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Charles E MakasiNational Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania.ORCID 0000-0002-2484-617X
Andrew M KilaleNational Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania.
Bernard J NgowiNational Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania.
Yakobo LemaNational Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania.
Victor KatitiDepartment of Epidemiology and Biostatistics, Institute of Public Health, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Michael J MahandeKilimanjaro Christian Medical University College of Tumaini University, Moshi, Tanzania.
Elizabeth F MsokaKilimanjaro Christian Medical University College of Tumaini University, Moshi, Tanzania.
Dominik StelzleCenter for Global Health, Department of Neurology, Faculty of Medicine, Technical University Munich, Munich, Germany.ORCID 0000-0001-6743-2818
Andrea S WinklerCenter for Global Health, Department of Neurology, Faculty of Medicine, Technical University Munich, Munich, Germany.
Blandina T MmbagaKilimanjaro Christian Medical University College of Tumaini University, Moshi, Tanzania.
Tumaini University · TZMuhimbili National Hospital · TZKilimanjaro Christian Medical Centre · TZTechnical University of Munich · DEUniversity of Dar es Salaam · TZUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTaenia solium (T. solium) neurocysticercosis (NCC) affects the central nervous system and is associated with 30% of acquired epilepsy in some endemic areas. Epilepsy is a stigmatizing disease in many societies and people with epilepsy (PWE) and their families experience discrimination. This study aimed to explore the knowledge, perceptions, and experiences of epilepsy among PWE and their caregivers attending mental health clinics.

methodsIn T. solium endemic areas of Tanzania, PWE and their caregivers attending mental health clinics were identified and their informed consent was sought prior to study participation. In-depth interviews were conducted in Swahili language and analyzed thematically. The coding was undertaken by two independent researchers using NVivo (Version 12, QSR International).

resultsThirty-eight participants were interviewed. Three themes were identified during the analysis, namely, knowledge about epilepsy; perception of epilepsy; and experience with epilepsy among PWE and their caregivers. Participants commonly defined epilepsy as a "falling disease," perceived to be caused by witchcraft, and were unaware of the association between T. solium and epilepsy. Stigmatization of epilepsy was reported as a problem. Reported treatment patterns after the initial onset of epilepsy varied widely; however, patients usually began treatment with traditional healing methods, and only later opted for biomedical treatment. Patients had generally poor adherence to antiseizure medication, which could be caused by inadequate knowledge or irregular supply. SIGNIFICANCE: Level of knowledge about epilepsy was low, and NCC was not mentioned as a cause of epilepsy among participants. Epilepsy was generally perceived to be the result of witchcraft, evil spirits, or curses. Health education is needed, including an explanation of the model of T. solium transmission and the insistence on hygiene measures. This could reduce the number of new infections with T. solium, improve access to prompt biomedical treatment, and improve the lives of PWE.

Indexed as

EpilepsyNeurocysticercosisTaenia soliumAnimalsCaregiversHumansMental HealthSwineTanzaniaCYSTINET-AfricaneurocysticercosisseizuresTaenia soliumTanzania

Identifiers

PMID36896648
PMCPMC10235557
OpenAlexW4323809906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.